{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:49:18Z","timestamp":1767340158224,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12094-021-02626-5","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:18:31Z","timestamp":1620076711000},"page":"2181-2190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characterization of a xenograft model for anti-CD19 CAR T cell studies"],"prefix":"10.1007","volume":"23","author":[{"given":"N.","family":"Ahmadbeigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alatab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vasei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Khorsand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Moradzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Darvishyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-7332","authenticated-orcid":false,"given":"S.","family":"Muhammadnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"2","key":"2626_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4049\/jimmunol.1701155","volume":"200","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Riddell SR, Alerts E. Chimeric antigen receptor T cell therapy: challenges to bench-to-bedside efficacy. J Immunol. 2018;200(2):459\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1701155.","journal-title":"J Immunol"},{"key":"2626_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","volume":"10","author":"M Martinez","year":"2019","unstructured":"Martinez M. Moon E K (2019) CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front Immunol. 2019;10:128. https:\/\/doi.org\/10.3389\/fimmu.2019.00128.","journal-title":"Front Immunol"},{"issue":"5","key":"2626_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"A Miranda","year":"2019","unstructured":"Miranda A, Marion F, Ariana P, Rafael Z, Gragera M, Steliarova E, et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control. 2019;30(5):489\u201399. https:\/\/doi.org\/10.1007\/s10552-019-01155-5.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"2626_CR4","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1097\/HS9.0000000000000185","volume":"3","author":"G Hopfinger","year":"2019","unstructured":"Hopfinger G, J\u00e4ger U, Worel N, Worel CN. CAR-T cell therapy in diffuse large B cell lymphoma: hype and hope. Hemasphere. 2019;3(2):e185. https:\/\/doi.org\/10.1097\/HS9.0000000000000185.","journal-title":"Hemasphere"},{"issue":"5","key":"2626_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2217\/imt.14.123","volume":"7","author":"M Kalaitsidou","year":"2015","unstructured":"Kalaitsidou M, Gilham DE. CAR T-cell therapy\u202f: toxicity and the relevance of preclinical models. Immunotherapy. 2015;7(5):487\u201397. https:\/\/doi.org\/10.2217\/imt.14.123.","journal-title":"Immunotherapy"},{"key":"2626_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0423-1","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wu Z, Liu Y, Han W. New development in CAR-T cell therapy. J Hematol Oncol. 2017. https:\/\/doi.org\/10.1186\/s13045-017-0423-1.","journal-title":"J Hematol Oncol"},{"key":"2626_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fonc.2017.00022","volume":"7","author":"R Kuhnken","year":"2017","unstructured":"Kuhnken R, Porcu P, Mishra A. Overview of the use of murine models in leukemia and lymphoma. Front Oncol. 2017;7:22. https:\/\/doi.org\/10.3389\/fonc.2017.00022.","journal-title":"Front Oncol"},{"issue":"11","key":"2626_CR8","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/TP.0b013e3181a5cb07","volume":"87","author":"R Ito","year":"2009","unstructured":"Ito R, Katano I, Hirata H, Ogura T, Kamisako T, Eto T, et al. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation. 2009;87(11):1654\u20138. https:\/\/doi.org\/10.1097\/TP.0b013e3181a5cb07.","journal-title":"Transplantation"},{"issue":"1","key":"2626_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.leu.2403534","volume":"19","author":"MB Karpova","year":"2005","unstructured":"Karpova MB, Schoumans J, Ernberg I, Henter JI, Nordenskj\u00f6ld M, Fadeel B. Raji revisited: cytogenetics of the original Burkitt\u2019s lymphoma cell line. Leukemia. 2005;19(1):159\u201361. https:\/\/doi.org\/10.1038\/sj.leu.2403534.","journal-title":"Leukemia"},{"issue":"11","key":"2626_CR10","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, A boagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102(11):1555\u201377. https:\/\/doi.org\/10.1038\/sj.bjc.6605642.","journal-title":"Br J Cancer"},{"issue":"4","key":"2626_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND. How to calculate sample size in animal studies? Educ Forum. 2013;4(4):303\u20136. https:\/\/doi.org\/10.4103\/0976-500X.119726.","journal-title":"Educ Forum"},{"issue":"3","key":"2626_CR12","first-page":"319","volume":"49","author":"MH Ullman-culler\u00e9","year":"1999","unstructured":"Ullman-culler\u00e9 MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999;49(3):319\u201323.","journal-title":"Lab Anim Sci"},{"issue":"2","key":"2626_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcyt.2019.12.004","volume":"22","author":"P Braendstrup","year":"2020","unstructured":"Braendstrup P, Levine BL, Ruella M. The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19. Cytotherapy. 2020;22(2):57\u201369. https:\/\/doi.org\/10.1016\/j.jcyt.2019.12.004.","journal-title":"Cytotherapy"},{"issue":"8","key":"2626_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/2326-6066.CIR-16-0043","volume":"4","author":"R Sakemura","year":"2016","unstructured":"Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, et al. A tet-on inducible system for controlling cd19-chimeric antigen receptor expression upon drug administration. Cancer Immunol Res. 2016;4(8):658\u201368. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0043.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"2626_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/2326-6066.CIR-15-0231","volume":"4","author":"E Zah","year":"2016","unstructured":"Zah E, Lin M, Silva-benedict A, Jensen MC, Chen YY. T cells expressing CD19\/CD20 Bispeci fi c chimeric antigen receptors prevent antigen escape by malignant B cells. Cancer Immunol Res. 2016;4(6):498\u2013508. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0231.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"2626_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nbt.3461","volume":"34","author":"L Liu","year":"2016","unstructured":"Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell SR. Inclusion of strep-tag II in design of antigen receptors for T cell immunotherapy. Nat Biotechnol. 2016;34(4):430\u20134. https:\/\/doi.org\/10.1038\/nbt.3461.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2626_CR17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/leu.2017.57","volume":"31","author":"D Sommermeyer","year":"2017","unstructured":"Sommermeyer D, Hill T, Shamah SM, Salter AI, Chen Y, Mohler KM, et al. Fully human CD19-specific chimeric antigen receptors for T cell therapy. Leukemia. 2017;31(10):2191\u20139. https:\/\/doi.org\/10.1038\/leu.2017.57.","journal-title":"Leukemia"},{"issue":"9","key":"2626_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","volume":"36","author":"S Rafiq","year":"2018","unstructured":"Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, Van LDG, Drakes DJ, et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat Publ Gr. 2018;36(9):847\u201356. https:\/\/doi.org\/10.1038\/nbt.4195.","journal-title":"Nat Publ Gr"},{"issue":"6","key":"2626_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","volume":"25","author":"Z Ying","year":"2019","unstructured":"Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, et al. A safe and potent anti-CD19 CAR T cell therapy. Nat Med. 2019;25(6):947\u201353. https:\/\/doi.org\/10.1038\/s41591-019-0421-7.","journal-title":"Nat Med"},{"issue":"3","key":"2626_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.cji.0000203078.97493.c3","volume":"29","author":"CC Petersen","year":"2006","unstructured":"Petersen CC, Petersen MS, Agger R, Hokland ME. Accumulatiomulation in tumor tissue of adoptively transferred T cells: a comparison between intravenous and intraperitoneal injection. J Immunother. 2006;29(3):241\u20139. https:\/\/doi.org\/10.1097\/01.cji.0000203078.97493.c3.","journal-title":"J Immunother"},{"issue":"7222","key":"2626_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456(7222):593\u20138. https:\/\/doi.org\/10.1038\/nature07567.","journal-title":"Nature"},{"key":"2626_CR22","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/ijc.23772","volume":"123","author":"A Agliano","year":"2008","unstructured":"Agliano A, Martin-padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G, et al. Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2R c null mice generate a faster and more efficient disease compared to other NOD\/scid-related strains. Int J Cancer. 2008;123:2222. https:\/\/doi.org\/10.1002\/ijc.23772.","journal-title":"Int J Cancer"},{"issue":"2","key":"2626_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbrc.2003.11.120","volume":"313","author":"Y Miyakawa","year":"2004","unstructured":"Miyakawa Y, Ohnishi Y, Tomisawa M, Monnai M, Kohmura K, Ueyama Y, et al. Establishment of a new model of human multiple myeloma using (NOG) mice NOD\/SCID. Biochem Biophys Res Commun. 2004;313(2):258\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.120.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2626_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13244-019-0733-7","volume":"10","author":"K Kalisz","year":"2019","unstructured":"Kalisz K, Alessandrino F, Beck R, Smith D, Kikano E, Ramaiya NH, et al. An update on Burkitt lymphoma\u202f: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging. 2019;10(1):56. https:\/\/doi.org\/10.1186\/s13244-019-0733-7.","journal-title":"Insights Imaging"},{"key":"2626_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph0528s18","author":"M Hollingshead","year":"2002","unstructured":"Hollingshead M. Intraperitoneal and subcutaneous tumor models for assessing anti-neoplastic agents. Curr Protoc Pharmacol. 2002. https:\/\/doi.org\/10.1002\/0471141755.ph0528s18.","journal-title":"Curr Protoc Pharmacol"},{"key":"2626_CR26","volume-title":"The Chemotherapy Source Book","author":"MC Perry","year":"2012","unstructured":"Perry MC, Doll DC. The Chemotherapy Source Book. 5th ed. Kindle Edition; 2012.","edition":"5"},{"issue":"2","key":"2626_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41409-018-0244-z","volume":"54","author":"E Wong","year":"2019","unstructured":"Wong E, Davis JE, Grigg A, Szer J. Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2019;54(2):175\u201389. https:\/\/doi.org\/10.1038\/s41409-018-0244-z.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2626_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jaut.2007.12.002","volume":"30","author":"AR Rezvani","year":"2009","unstructured":"Rezvani AR, Storb R. Separation of graft-vs-tumor effects from graft-vs-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun. 2009;30(3):172\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2007.12.002.","journal-title":"J Autoimmun."},{"issue":"5","key":"2626_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/hgtb.2013.022","volume":"24","author":"EM Alcantar-orozco","year":"2013","unstructured":"Alcantar-orozco EM, Gornall H, Baldan V, Hawkins RE, Gilham DE. Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer. Hum Gene Ther Methods. 2013;24(5):310\u201320. https:\/\/doi.org\/10.1089\/hgtb.2013.022.","journal-title":"Hum Gene Ther Methods"},{"issue":"6","key":"2626_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejim.2006.04.004","volume":"17","author":"V Sakka","year":"2006","unstructured":"Sakka V, Tsiodras S, Giamarellos-bourboulis EJ, Giamarellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006;17(6):394\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2006.04.004.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"2626_CR31","first-page":"234","volume":"59","author":"EV Paster","year":"2009","unstructured":"Paster EV, Villines KA, Hickman DL. Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp Med. 2009;59(3):234\u201341.","journal-title":"Comp Med"},{"key":"2626_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep30723","author":"TD Laajala","year":"2016","unstructured":"Laajala TD, Jumppanen M, Huhtaniemi R, Fey V, Kaur A, Knuuttila M, et al. Optimized design and analysis of preclinical intervention studies in vivo. Sci Rep Article number: 30723. 2016. https:\/\/doi.org\/10.1038\/srep30723.","journal-title":"Sci Rep Article number: 30723"},{"issue":"1","key":"2626_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-5380-1-9","volume":"1","author":"C Belzung","year":"2011","unstructured":"Belzung C, Lemoine M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord. 2011;1(1):1\u201314.","journal-title":"Biol Mood Anxiety Disord"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-021-02626-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T21:25:13Z","timestamp":1630013113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-021-02626-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2626"],"URL":"https:\/\/doi.org\/10.1007\/s12094-021-02626-5","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"13 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experimentation was conducted under a protocol approved by the Ethical Committee of Tehran University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work was a preclinical study. Therefore, informed consent was not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}